Two-dose-level confirmatory study of the pharmacokinetics and tolerability of everolimus in Chinese patients with advanced solid tumors

por Xu, BingHe, Wu, YiLong, Shen, Lin, Ye, DingWei, Jappe, Annette, Cherfi, Azzeddine, Wang, Hui, Yuan, RuiRong
Publicado 2011

Hormonal therapy might be a better choice as maintenance treatment than capecitabine after response to first-line capecitabine-based combination chemotherapy for patients with horm...

por Chen, Xue-Lian, Du, Feng, Hong, Ruo-Xi, Wang, Jia-Yu, Luo, Yang, Li, Qing, Fan, Ying, Xu, Bing-He
Publicado 2016

Impact of coronavirus disease 2019 on the clinical diagnosis and treatment of breast cancer in China

por Si, Yi-Ran, Du, Feng, Hu, Nan-Lin, Wang, Xue, Yue, Jian, Jiang, Pei-Di, Xu, Bing-He, Yuan, Peng
Publicado 2021

Switching to anastrozole plus goserelin vs continued tamoxifen for adjuvant therapy of premenopausal early-stage breast cancer: preliminary results from a randomized trial

por Li, Jian-wei, Liu, Guang-yu, Ji, Ya-jie, Yan, Xia, Pang, Da, Jiang, Ze-fei, Chen, De-dian, Zhang, Bin, Xu, Bing-he, Shao, Zhi-ming
Publicado 2018

Assessing early changes in plasma HER2 levels is useful for predicting therapeutic response in advanced breast cancer: A multicenter, prospective, noninterventional clinical study

por Kang, Yi‐Kun, Si, Yi‐Ran, Ju, Jie, Jia, Zhu‐Qing, Hu, Nan‐Lin, Dong, Hao, Wang, Xue, Yue, Jian, Jiang, Pei‐Di, Li, Zhao‐Liang, Zhang, Yun‐Yun, Wang, Yan, Xu, Bing‐He, Yuan, Peng
Publicado 2022

Lapatinib plus capecitabine in treating HER2-positive advanced breast cancer: efficacy, safety, and biomarker results from Chinese patients

por Xu, Bing-He, Jiang, Ze-Fei, Chua, Daniel, Shao, Zhi-Min, Luo, Rong-Cheng, Wang, Xiao-Jia, Liu, Dong-Geng, Yeo, Winnie, Yu, Shi-Ying, Newstat, Beth, Preston, Alka, Martin, Anne-Marie, Chi, Hai-Dong, Wang, Li
Publicado 2011

Expression dynamics of periodic transcripts during cancer cell cycle progression and their correlation with anticancer drug sensitivity

por Li, Chun-Xiao, Wang, Jin-Song, Wang, Wen-Na, Xu, Dong-Kui, Zhou, Yan-Tong, Sun, Fang-Zhou, Li, Yi-Qun, Guo, Feng-Zhu, Ma, Jia-Lu, Zhang, Xue-Yan, Chang, Meng-Jiao, Xu, Bing-He, Ma, Fei, Qian, Hai-Li
Publicado 2022

Age at initial diagnosis and prognosis of breast cancer: a nationwide multicenter retrospective study in China

por Yang, Huan, Ouyang, Qu-Chang, Yan, Min, Wang, Xiao-Jia, Hu, Xi-Chun, Jiang, Ze-Fei, Huang, Tao, Tong, Zhong-Sheng, Wang, Shu-Sen, Yin, Yong-Mei, Li, Hui, Yang, Run-Xiang, Yang, Hua-Wei, Teng, Yue-E, Sun, Tao, Cai, Li, Li, Hong-Yuan, Ouyang, Xue-Nong, He, Jian-Jun, Liu, Xin-Lan, Yang, Shun-E, Fan, Jin-Hu, Wang, Jia-Yu, Qiao, You-Lin, Xu, Bing-He
Publicado 2022

Molecular subtypes predict the preferential site of distant metastasis in advanced breast cancer: a nationwide retrospective study

por Fan, Jin-Hu, Zhang, Su, Yang, Huan, Yi, Zong-Bi, Ouyang, Qu-Chang, Yan, Min, Wang, Xiao-Jia, Hu, Xi-Chun, Jiang, Ze-Fei, Huang, Tao, Tong, Zhong-Sheng, Wang, Shu-Sen, Yin, Yong-Mei, Li, Hui, Yang, Run-Xiang, Yang, Hua-Wei, Teng, Yue-E., Sun, Tao, Cai, Li, Li, Hong-Yuan, Ouyang, Xue-Nong, He, Jian-Jun, Liu, Xin-Lan, Yang, Shun-E., Wang, Jia-Yu, Xu, Bing-He, Qiao, You-Lin
Publicado 2023

Comparisons of Treatment for HER2-Positive Breast Cancer between Chinese and International Practice: A Nationwide Multicenter Epidemiological Study from China

por Han, Yi-Qun, Yi, Zong-Bi, Yu, Pei, Wang, Wen-Na, Ouyang, Qu-Chang, Yan, Min, Wang, Xiao-Jia, Hu, Xi-Chun, Jiang, Ze-Fei, Huang, Tao, Tong, Zhong-Sheng, Wang, Shu-Sen, Yin, Yong-Mei, Li, Hui, Yang, Run-Xiang, Yang, Hua-Wei, Teng, Yue-E., Sun, Tao, Cai, Li, Li, Hong-Yuan, Ouyang, Xue-Nong, He, Jian-Jun, Liu, Xin-Lan, Yang, Shun-E., Qiao, You-Lin, Fan, Jin-Hu, Wang, Jia-Yu, Xu, Bing-He
Publicado 2021